Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06151392Phase 4Completed
Phase 4, randomised, open-label trial of zinc in ventriculitis (4 arms), sponsored by Ain Shams University. Primary endpoints: Cerebrospinal Fluid culture at 14 days, Normalization of the Cerebrospinal Fluid chemistry at 14 days and 1 more. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06151392.